Five Best And Worst Performing Small-Cap Stocks In Dec 2022

Published on

Small-cap stocks usually suffer more than mid- and large-cap stocks when the market as a whole is struggling, and when the market is rallying, they could offer higher returns as well. The year 2022 wasn’t good for the equity market, including small-cap stocks, but analysts expect quality small-cap stocks to offer exceptional returns in 2023. Let’s take a look at the five best and worst performing small-cap stocks in Dec 2022.

Five Best Performing Small-Cap Stocks In Dec 2022

We have taken the December return data of small-cap stocks from finviz.com to rank the five best and worst performing small-cap stocks in Dec 2022. Here are the five best performing small-cap stocks in Dec 2022:

Get The Full Ray Dalio Series in PDF

Get the entire 10-part series on Ray Dalio in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues

Q4 2022 hedge fund letters, conferences and more

 

  1. CymaBay Therapeutics (85%)

Founded in 1988 and headquartered in Newark, Calif., this company develops access to therapies for patients with liver and other chronic diseases. CymaBay Therapeutics Inc (NASDAQ:CBAY) shares are up by over 96% in the last three months and up almost 4% year to date.

As of this writing, CymaBay Therapeutics shares are trading above $6.40 with a 52-week range of $1.67 to $6.59, giving the company a market capitalization of more than $550 million.

  1. Avidity Biosciences (91%)

Founded in 2012 and headquartered in San Diego, Calif., this company develops oligonucleotide-based therapies. Avidity Biosciences Inc (NASDAQ:RNA) shares are up by over 38% in the last three months and up over 2% year to date.

As of this writing, Avidity Biosciences shares are trading above $22 with a 52-week range of $9.83 to $23.57, giving the company a market cap of more than $1.50 billion.

  1. Trean Insurance Group (117%)

Founded in 1996 and headquartered in Wayzata, Minn., this company offers insurance products and services with a focus on specialty casualty lines. Trean Insurance Group Inc (NASDAQ:TIG) shares are up by over 78% in the last three months and up almost 1% year to date.

As of this writing, Trean Insurance Group shares are trading above $6 with a 52-week range of $2.12 to $8.12, giving the company a market cap of more than $300 million.

  1. Viking Therapeutics (132%)

Founded in 2012 and headquartered in San Diego, this company develops novel therapies for patients suffering from metabolic and endocrine disorders. Viking Therapeutics Inc (NASDAQ:VKTX) shares are up by over 173% in the last three months but are down by almost 5% year to date.

As of this writing, Summit Therapeutics shares are trading above $9 with a 52-week range of $2.02 to $9.62, giving the company a market capitalization of more than $680 million.

  1. Summit Therapeutics (431%)

Founded in 2003 and headquartered in Abingdon, the United Kingdom, this company discovers, develops, and sells antibiotic medicines. Summit Therapeutics Inc (NASDAQ:SMMT) shares are up by almost 314% in the last three months and up almost 13% year to date.

As of this writing, Summit Therapeutics shares are trading above $4.70 with a 52-week range of $0.66 to $5.78, giving the company a market cap of more than $966 million.

Five Worst Performing Small-Cap Stocks In Dec 2022

Here are the five worst performing small-cap stocks in December 2022:

  1. Century Therapeutics (-51%)

Founded in 2018 and headquartered in Philadelphia, Pa., this company develops off-the-shelf cell therapies to advance the course of cancer care. Century Therapeutics Inc (NASDAQ:IPSC) shares are down by over 49% in the last three months and down almost 5% year to date.

As of this writing, Century Therapeutics shares are trading above $5.60 with a 52-week range of $4.02 to $44.00, giving the company a market capitalization of more than $520 million.

  1. Fate Therapeutics (-52%)

Founded in 2007 and headquartered in San Diego, this company develops programmed cellular immunotherapies for cancer and immune disorders. Fate Therapeutics Inc (NASDAQ:FATE) shares are down by over 73% in the last three months and down over 46% year to date.

As of this writing, Fate Therapeutics shares are trading above $5.60 with a 52-week range of $4.02 to $44.00, giving the company a market cap of more than $520 million.

 

  1. Alset (-55%)

Founded in 2018 and headquartered in Maryland, this company provides quality and affordable designer homes with integrated smart technologies. Alset Inc (NASDAQ:AEI) shares are down by over 33% in the last three months but are up by over 29% year to date.

As of this writing, Alset shares are trading above $2.90 with a 52-week range of $2.2509 to $18.5740, giving the company a market cap of more than $22 million.

  1. P3 Health Partners (-62%)

Founded in 2020 and headquartered in Henderson, Nev., this company offers professional support services to doctors and clinicians. P3 Health Partners Inc (NASDAQ:PIII) shares are down by almost 64% in the last three months and down almost 8% year to date.

As of this writing, P3 Health Partners shares are trading above $1.70 with a 52-week range of $1.43 to $8.49, giving the company a market cap of more than $410 million.

  1. Hall of Fame Resort & Entertainment (-97%)

Founded in 2015 and headquartered in Canton, Ohio, it is a resort and entertainment company. Hall of Fame Resort & Entertainment Co (NASDAQ:HOFV) shares are up by almost 15% in the last three months and up almost 75% year to date.

As of this writing, Hall of Fame Resort & Entertainment shares are trading above $14.50 with a 52-week range of $7.36 to $31.68, giving the company a market capitalization of more than $76 million.